TYME
Tyme Technologies Inc
Price:
0.31
USD
Volume:
2,609,750
United States | Biotechnology
TYME Relative Valuation
-1030.3 %
Upside
As of 2025-05-16, the Relative Valuation of Tyme Technologies Inc (TYME) is (2.89) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.31 USD, the upside of Tyme Technologies Inc based on Relative Valuation is -1030.3%.
The range of the Relative Valuation is (2.46) - (3.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.1x - 22.5x | 19.3x |
| Forward P/E multiples | 17.5x - 26.2x | 21.9x |
| Fair Price | (2.46) - (3.16) | (2.89) |
| Upside | -891.3% - -1116.4% | -1030.3% |
0.31 USD
Stock Price
(2.89) USD
Fair Price
| (USD in millions except Fair Price) | |||
| Market Cap (USD mil) | Trailing P/E | Forward P/E | |
| Tyme Technologies Inc | 54 | N/A | N/A |
| Abbvie Inc | 321,388 | 75.1x | 79x |
| Amgen Inc | 146,074 | 24.6x | 29.1x |
| Regeneron Pharmaceuticals Inc | 63,161 | 14x | 14.6x |
| Industry median | 19.3x | 21.9x | |
| (*) Profit after tax | -24 | -24 | |
| Equity value | -467 | -529 | |
| (/) Outstanding shares | 172 | 172 | |
| Fair price | -3 | -3 | |